Health Canada Warns Consumers Not to Use Encore Tabs for Men Due to Potential Health Risks

News Release

Warning
2007-77
June 25, 2007
For immediate release

OTTAWA - Health Canada is warning consumers not to use the product Encore Tabs for Men, because it contains an undeclared pharmaceutical ingredient similar to the approved drug tadalafil. Tadalafil is a prescription medication indicated for the treatment of erectile dysfunction and should only be used under the supervision of a health professional. The use of Encore Tabs for Men could pose serious health risks, especially for patients with existing medical conditions such as heart problems, those taking heart medication, or those at risk of stroke.
Products containing tadalafil should not be used by individuals who are taking any nitrate medication because combining these products could result in the development of potentially life-threatening low blood pressure.
The use of products containing tadalafil has been associated with serious side effects including serious cardiac events such as heart attacks, sudden cardiac death, angina, irregular heart rate, or stroke. In extremely rare instances, use of tadalafil may potentially result in penile tissue damage and permanent loss of potency.
Encore Tabs for Men is advertised as a dietary supplement for sexual enhancement and is not authorized for sale in Canada. The Canadian importer has been contacted and is recalling the product. Consumers who have purchased Encore Tabs for Men are warned not to use the product and to consult with a medical professional if they have used it or have concerns about their health.
Encore Tabs for Men is sold in blister packages. There have been no reports of adverse reactions associated with the use of this product. Health Canada is taking steps to confirm that the product has been removed from the Canadian market. The product was available at retail outlets and may also be sold over the Internet. More information about purchasing drugs over the internet is available on the Health Canada Web site.
Consumers requiring more information about this warning can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
To report a suspected adverse reaction to this product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
CADRMP
Marketed Health Products Directorate Tunney's Pasture, AL 0701C
email: cadrmp@hc-sc.gc.ca
The CADRMP adverse reaction reporting form, including a version that can be completed and submitted online, is located on the MedEffect area of the Health Canada Web site.
- 30 -

Media Inquiries:
Health Canada
(613) 957-2983
Public Inquiries:
(613) 957-2991
1-866 225-0709

Search for related information by keyword

Health Canada Processes Health and Safety

Page details

2016-12-15

We have archived this page and will not be updating it.

We have archived this page and will not be updating it.

Health Canada Warns Consumers Not to Use Encore Tabs for Men Due to Potential Health Risks

News Release

Page details